Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 1/20 | 0.93 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6382415 | 0.93 | CHRNA7 (0.93) | CHRNA7 | |
| SCHEMBL10884827 | 0.93 | CHRNA7 (0.93) | CHRNA7 | |
| SCHEMBL10884820 | 0.93 | CHRNA7 (0.93) | CHRNA7 | |
| Water SCHEMBL9979643 | 0.93 | CHRNA7 (0.93) | CHRNA7 | |
| Bromide SCHEMBL11250560 | 0.82 | CHRNA7 (0.72) | CHRNA7 | |
| Bicarbonate SCHEMBL3621286 | 0.80 | CHRNA7 (0.68) | CHRNA7 | |
| Bicarbonate SCHEMBL3621287 | 0.78 | CHRNA7 (0.65) | CHRNA7 | |
| Bromide SCHEMBL11577972 | 0.73 | — | — | |
| SCHEMBL13429190 | 0.67 | — | — | |
| SCHEMBL3391562 | 0.66 | CHRNA7 (0.50) | CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3009400-B1 | NU-3 LEV-TYPE ZEOLITE AND PRODUCTION METHOD THEREFOR | TOSOH CORP (JP) | 2022-11-30 | — | — | EP | disclosed |
| US-7361668-B2 | Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors | UCB, S.A. (BE) | 2008-04-22 | — | — | US | disclosed |
| US-20050020660-A1 | Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors | UCB, S.A. (BE) | 2005-01-27 | — | — | US | disclosed |
| EP-0040015-B1 | PROCESS FOR MAKING OLEFINS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-06-11 | — | — | EP | disclosed |
| EP-0040016-B1 | ZEOLITE NU-3 | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-09-12 | — | — | EP | disclosed |
| US-4372930-A | Zeolite Nu-3 | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1983-02-08 | — | — | US | disclosed |
| US-4361715-A | CATALYZED BY ZEOLITE NU-3 | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-11-30 | — | — | US | disclosed |
| US-4338118-A | OF COTTON WITH BICYCLIC QUATERNARY AMMONIUM SALTS | ELI LILLY AND COMPANY (US) | 1982-07-06 | — | — | US | disclosed |
| EP-0040015-A1 | Process for making olefins | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-11-18 | — | — | EP | disclosed |
| EP-0040016-A1 | Zeolite Nu-3 | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020660-A1 | Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors | CHRM2, CHRM3, CHRM1 | CHRNA7 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.